Treatment with abiraterone significantly improves survival in advanced prostate cancer

In December, researchers reported findings from a study showing that the drug abiraterone halves the risk of prostate cancer death among a specific group of patients who previously would not…

Continue ReadingTreatment with abiraterone significantly improves survival in advanced prostate cancer